Tokyo, Japan

Schirou Noji

This inventor holds 1 USPTO granted patent. Top assignee: Ube Industries, Inc.. Active years: 1990.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Schirou Noji: Innovator in Diagnostic Testing

Introduction

Schirou Noji is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of diagnostic testing, particularly in relation to human health. His innovative work has led to the development of a unique measurement reagent that plays a crucial role in cancer diagnostics.

Latest Patents

Schirou Noji holds a patent for a diagnostic test drug comprising a monoclonal antibody to human Cu.Zn-superoxide dismutase (SOD). This patent includes a measurement reagent for human Cu.Zn-SOD, which is essential for diagnosing stomach cancer. The method involves using an enzyme-linked immunosorbent assay according to the sandwich method, showcasing his expertise in biochemistry and medical diagnostics.

Career Highlights

Noji is associated with Ube Industries, Inc., where he has been able to apply his knowledge and skills in a practical setting. His work has not only advanced scientific understanding but has also contributed to the development of effective diagnostic tools for cancer detection.

Collaborations

Throughout his career, Schirou Noji has collaborated with notable colleagues, including Takashi Usagawa and Taizo Uda. These partnerships have fostered innovation and have been instrumental in the success of his projects.

Conclusion

Schirou Noji's contributions to diagnostic testing exemplify the impact of innovative thinking in healthcare. His work continues to influence the field and improve diagnostic methods for critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…